There have been 50 recent insider transactions recorded for Neurocrine Biosciences, Inc. (NBIX), including 11 buys and 35 sells. Total insider buying was valued at $796.9K and total insider selling at $4.51M.
Notable insiders with recent activity include Ratz Andrew, Abernethy Matt, Onyia Jude. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — NBIX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-15 |
Ratz Andrew |
Chief Technical Operations Off |
Unknown |
805 |
$124.12 |
$99.92K |
- |
| 2026-03-04 |
Abernethy Matt |
Chief Financial Officer |
Gift (Given) |
2,249 |
- |
- |
42,808 |
| 2026-02-20 |
Onyia Jude |
Chief Scientific Officer |
Gift (Given) |
3,110 |
- |
- |
25,670 |
| 2026-02-13 |
Lippoldt Darin |
Chief Legal Officer |
Option Exercise (Sell) |
2,083 |
- |
- |
2,083 |
| 2026-02-13 |
Gano Kyle |
Chief Executive Officer |
Option Exercise (Sell) |
2,566 |
- |
- |
2,566 |
| 2026-02-13 |
Benevich Eric |
Chief Commercial Officer |
Option Exercise (Sell) |
2,083 |
- |
- |
2,083 |
| 2026-02-13 |
Abernethy Matt |
Chief Financial Officer |
Option Exercise (Sell) |
2,566 |
- |
- |
2,566 |
| 2026-02-13 |
Cooke Julie |
Chief Human Resources Officer |
Option Exercise (Sell) |
1,510 |
- |
- |
1,510 |
| 2026-02-13 |
Onyia Jude |
Chief Scientific Officer |
Option Exercise (Sell) |
2,717 |
- |
- |
2,717 |
| 2026-02-13 |
Boyer David W. |
Chief Corp. Affairs Officer |
Option Exercise (Sell) |
1,811 |
- |
- |
1,812 |
| 2026-02-12 |
Lippoldt Darin |
Chief Legal Officer |
Option Exercise (Sell) |
1,792 |
- |
- |
5,377 |
| 2026-02-12 |
Gano Kyle |
Chief Executive Officer |
Option Exercise (Sell) |
4,907 |
- |
- |
14,721 |
| 2026-02-12 |
Benevich Eric |
Chief Commercial Officer |
Option Exercise (Sell) |
2,005 |
- |
- |
6,017 |
| 2026-02-12 |
Abernethy Matt |
Chief Financial Officer |
Option Exercise (Sell) |
2,133 |
- |
- |
6,401 |
| 2026-02-12 |
Cooke Julie |
Chief Human Resources Officer |
Option Exercise (Sell) |
1,387 |
- |
- |
4,161 |
| 2026-02-12 |
Onyia Jude |
Chief Scientific Officer |
Option Exercise (Sell) |
2,560 |
- |
- |
7,681 |
| 2026-02-12 |
Boyer David W. |
Chief Corp. Affairs Officer |
Option Exercise (Sell) |
1,600 |
- |
- |
4,801 |
| 2025-06-02 |
Keswani Sanjay Chandru |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-06-02 |
Keswani Sanjay Chandru |
Chief Medical Officer |
RSU Award |
12,846 |
- |
- |
12,846 |
| 2025-05-27 |
Gorman Kevin Charles |
Director |
Informative Sell |
9,613 |
$120.38 |
$1.16M |
514,596 |
| 2025-05-22 |
Morrow George J |
Director |
Option Exercise (Sell) |
2,869 |
- |
- |
- |
| 2025-05-22 |
Sherwin Stephen A |
Director |
Option Exercise (Sell) |
2,869 |
- |
- |
- |
| 2025-05-22 |
Lyons Gary A |
Director |
Option Exercise (Sell) |
1,435 |
- |
- |
- |
| 2025-05-22 |
Pops Richard F |
Director |
Option Exercise (Sell) |
2,869 |
- |
- |
- |
| 2025-05-22 |
Poon Christine A |
Director |
Option Exercise (Sell) |
1,435 |
- |
- |
- |
| 2025-05-22 |
Rastetter William H |
Director |
Option Exercise (Sell) |
2,869 |
- |
- |
- |
| 2025-05-22 |
Sharp Shalini |
Director |
Option Exercise (Sell) |
1,435 |
- |
- |
- |
| 2025-05-22 |
Norwalk Leslie V |
Director |
Option Exercise (Sell) |
1,435 |
- |
- |
- |
| 2025-05-22 |
Mercier Johanna |
Director |
Option Exercise (Sell) |
1,435 |
- |
- |
- |
| 2025-05-21 |
Morrow George J |
Director |
RSU Award |
3,318 |
- |
- |
3,318 |
| 2025-05-21 |
Sherwin Stephen A |
Director |
RSU Award |
3,318 |
- |
- |
3,318 |
| 2025-05-21 |
Lyons Gary A |
Director |
RSU Award |
1,659 |
- |
- |
1,659 |
| 2025-05-21 |
Pops Richard F |
Director |
RSU Award |
3,318 |
- |
- |
3,318 |
| 2025-05-21 |
Poon Christine A |
Director |
RSU Award |
3,318 |
- |
- |
3,318 |
| 2025-05-21 |
Gorman Kevin Charles |
Director |
RSU Award |
6,610 |
$120.56 |
$796.9K |
6,610 |
| 2025-05-21 |
Rastetter William H |
Director |
RSU Award |
3,318 |
- |
- |
3,318 |
| 2025-05-21 |
Sharp Shalini |
Director |
RSU Award |
1,659 |
- |
- |
1,659 |
| 2025-05-21 |
Norwalk Leslie V |
Director |
RSU Award |
1,659 |
- |
- |
1,659 |
| 2025-05-21 |
Mercier Johanna |
Director |
RSU Award |
3,318 |
- |
- |
3,318 |
| 2025-05-16 |
Cooke Julie |
Chief Human Resources Officer |
Option Exercise (Sell) |
6,468 |
$61.82 |
$399.85K |
- |
| 2025-05-05 |
Rastetter William H |
Director |
Option Exercise (Sell) |
30,000 |
$42.76 |
$1.28M |
- |
| 2025-02-14 |
Roberts Eiry |
Chief Medical Officer |
Informative Sell |
500 |
$115.04 |
$57.52K |
35,640 |
| 2025-02-13 |
Sherwin Stephen A |
Director |
Informative Sell |
13,831 |
$116.69 |
$1.61M |
10,673 |
| 2025-02-13 |
Gorman Kevin Charles |
Director |
Option Exercise (Sell) |
5,376 |
- |
- |
10,754 |
| 2025-02-13 |
Lippoldt Darin |
Chief Legal Officer |
Option Exercise (Sell) |
2,083 |
- |
- |
4,166 |
| 2025-02-13 |
Gano Kyle |
Chief Executive Officer |
Option Exercise (Sell) |
2,566 |
- |
- |
5,132 |
| 2025-02-13 |
Benevich Eric |
Chief Commercial Officer |
Option Exercise (Sell) |
2,083 |
- |
- |
4,166 |
| 2025-02-13 |
Abernethy Matt |
Chief Financial Officer |
Option Exercise (Sell) |
2,566 |
- |
- |
5,132 |
| 2025-02-13 |
Roberts Eiry |
Chief Medical Officer |
Option Exercise (Sell) |
1,120 |
- |
- |
3,363 |
| 2025-02-13 |
Cooke Julie |
Chief Human Resources Officer |
Option Exercise (Sell) |
1,509 |
- |
- |
3,020 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
